Lisa Caperelli | VP of IR |
Bill Collier | President, CEO and Director |
David Hastings | CFO |
Karen Sims | VP of Clinical Development |
Michael Sofia | Chief Scientific Officer |
Roy Buchanan | JMP |
Dennis Ding | Jefferies |
Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Q2 Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Lisa Caperelli. Please go ahead.